(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)
The S&P 500 was little changed on Monday, with investors mostly taking a pause following a sharp rally on Friday, though both the benchmark index and the Dow inched up to new intraday records. The Dow Jones industrial average was down 0.14 percent at 17,365.71, the S&P 500 was up 0.12 percent at 2,020.38 and the Nasdaq Composite was up 0.40 percent at 4,649.473.
** SAPIENT CORP, $24.61, +42.09 pct
Publicis, the world’s third-largest advertising agency, has agreed to buy the digital ad specialist for $3.7 billion in cash as it seeks to accelerate growth after a botched merger earlier this year.
** NYMOX PHARMACEUTICALS CO, $0.8289, -83.87 pct
The drug developer said its drug, NX-1207, to treat benign prostatic hyperplasia (BPH), or enlargement of the prostate, failed to meet the main goals of two late-stage studies.
** CHANGYOU.COM LTD, $26.01, +8.19 pct
The China-based game developer reported a better-than-expected third quarter profit as it signed up more users for its online game Tian Long Ba Bu, also called Dragon Oath.
** AMERICAN REALTY CAPITAL PROPERTIES, $8.29, -6.54 pct
** RCS CAPITAL CORP,, $13.99, -14.75 pct
U.S. authorities have opened a criminal probe in the wake of American Realty’s disclosure that it had uncovered accounting errors, two sources familiar with the matter said on Friday.
RCS Capital Corp terminated an agreement to buy American Realty unit Cole Capital, but did not disclose a reason.
** COVANCE INC, Friday close $100.4, +25.66 pct
** LABORATORY CORP OF AMERICA HOLDINGS, $101.3, -7.31 pct
Laboratory Corp, a provider of healthcare diagnostic services, said it would buy contract research company Covance for about $6.1 billion in cash and stock.
** GERON CORP, $2.9, +30.04 pct
The drugmaker said the U.S. FDA removed a full clinical hold on the investigational new drug application for its treatment, imetelstat, for a rare form of blood cancer.
A mid-stage trial of treatment, which is being tested for myelofibrosis, is expected to begin in first half of 2015, it said.
** AMREIT INC, $26.38, +7.06 pct
The U.S. shopping mall owner will be bought by Edens Investment Trust for $522.6 million, or $26.55 per share, a premium of nearly 8 percent to AmREIT’s Friday closing price.
** SYSCO CORP, $37.54, -2.59 pct
The food distributor said it did not expect to complete its acquisition of US Foods Inc this year and it was still in talks with U.S. antitrust regulators to secure approval for the deal.
** HERBALIFE LTD, $54.02, +2.97 pct
The nutrition and supplements company will pay $15 million to settle an 18-month battle over a class action lawsuit brought by a former distributor claiming that the company is running an alleged pyramid scheme, according to a U.S. court filing.
** PORTUGAL TELECOM, $1.7, +4.29 pct
Altice SA said it made a fully financed offer to buy the Portuguese assets of the company from Oi SA .
** ANGLOGOLD ASHANTI LTD, $9.55, +15.48 pct
The South African gold producer, which runs the world’s deepest mines, said on Monday it had completed six months without any fatalities, a first for a company that has struggled with the industry’s “zero harm” target.
** RYANAIR HOLDINGS PLC, $58.75, +5.78 pct
The Irish carrier raised its annual profit forecast almost 20 percent on Monday thanks to a surge in winter bookings and said it would cut fares by up to 10 percent in the new year to take more market share from struggling airline rivals. (Compiled by Avik Das in Bangalore; Editing by Simon Jennings)